Our updated guideline to improve the diagnosis of endometriosis
The guideline makes new recommendations and updates existing ones on diagnosing and managing a condition that affects approximately 1.5 million women of reproductive age in the UK.
The guideline makes new recommendations and updates existing ones on diagnosing and managing a condition that affects approximately 1.5 million women of reproductive age in the UK.
Our updated guideline on menopause emphasises the importance of an individualised approach and shared decision-making when making choices about treatment for symptoms.
Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their cholesterol during 2023/24, the largest number on record and almost 900,000 more than in 2022/23.
Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October).
How we make independent decisions on the cost and clinical effectiveness of medicines and treatments.
How Clatterbridge Cancer Centre improved early detection rates of metatstatic spinal cord compression, and increased the average survival rates of patients through following our recommendations.
Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and introducing new technologies can be daunting. Here are my top tips for smoothing your product's journey from development to patient access.
Lead with confidence through our Executive MSc in Healthcare Decision-Making.